InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes New Research Backing Its Approach to Outcome-Based Engagement
August 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced new research presented at the ADCES23 Annual Conference that took place earlier this month in Houston, Texas. According to the announcement, the research demonstrates Dario’s ability to sustainably improve health outcomes for users with diabetes over a two-year period. “Dario’s solutions are […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with PlanSource to Provide Key Digital Health Solutions
August 15, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has inked a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology. The agreement, which expands Dario’s reach in the employer market, calls for the company to offer integrated digital health solutions to more than 5 million consumers. Dario’s […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q2 2023 Results
August 10, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the second quarter 2023 and provided a corporate and commercial update. “During the second quarter, we saw a continuation of the many positive trends that have contributed to our improved financial profile, including growing revenue contribution from highly scalable […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Agreement with Large Regional Health Plan
August 8, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced the expansion of its partnership with a large regional health plan to deliver highly personalized digital health solutions to plan members living with diabetes. The launch is anticipated to take place in the first quarter of 2024. “Our ability to engage members […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q2 2023 Results, Conference Call and Webcast
August 3, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced that it will release its financial results for the second quarter ended June 30, 2023, before market opens on Thursday, Aug. 10, 2023. Also on Aug. 10, the company will host a conference call and webcast at 8:30 a.m. Eastern Time, led […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Behavior Program to Support Weight Loss, Better Health
August 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is offering a new program designed to provide support for individuals using GLP-1s and other anti-obesity drugs. The program is designed to support changes in behavior and help users leverage the full potential of medications while improving overall health; the program also has potential […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Shares New Research Supporting Significant Medical Costs Savings for Dario Users
July 26, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a new analysis by Sanofi U.S. demonstrating a significant reduction in the cost of care for Dario users compared to non-users living with type 2 diabetes. According to the announcement, the study used matched claims to show an estimated $5,077 in medical […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Large Regional Health Plan to Client List, Reports on Q2 2023 Preliminary Results
July 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has added a new agreement with a large regional health plan to its client list. According to the announcement, DRIO will deliver highly personalized digital health solutions to more than 160,000 plan members living with hypertension; the plan will launch this month. DRIO noted […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds New Full-Suite Employer to Growing Number of Contracts
July 6, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is adding a new employer contract to its growing list of clients. The new full-suite account is scheduled to launch later this year, and the company expects it to add to revenue for the year. According to the company, the new account is a […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Key Research Presented at ABA Scientific Sessions
June 26, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, reported on a retrospective cohort study at the recent American Diabetes Association (“ABA”) 83rd Scientific Sessions. According to the announcement, the study analyzed real-world data of Dario users against matched controls, with results showing significant improvements in HbA1c for Dario users with serious diabetes. […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Two New Contracts for Integrated Solutions
June 7, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced two new employer contracts for the company’s full suite of integrated solutions. According to the update, the new accounts are scheduled to launch in the second half of 2023. “Managing the rising cost of chronic conditions with a significant return on investment […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO to Present at Upcoming Stifel Virtual Cross Sector Insight Conference
June 1, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be attending and participating in the Stifel 2023 Virtual Cross Sector Insight Conference. The two-day event is scheduled to be held in Boston on June 6–7, 2023. According to the announcement, DarioHealth president Rick Anderson will be presenting at the conference; his presentation […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Solutions to MedOne Members
May 18, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global health market, and MedOne Pharmacy Benefit Solutions (“PBM”), a national leader in modern pharmacy benefits management, today announced a new agreement to integrate Dario’s suite of digital health solutions as a complement to MedOne’s digital diabetes solution, the Diabetes Care Path. According to the update, the collaboration […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q1 Financial and Operating Results
May 11, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced financial results for the first quarter 2023 and provided a corporate and commercial update. “During the first quarter, we continued to improve the financial profile of the company as we capitalized on the growing demand for digital health solutions in the […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Research Presented at Leading Global Conference for Health Economics
May 9, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, announced the presentation of research at ISPOR 2023, the leading global conference for health economics and outcomes research. The conference was on May 7–10, 2023, in Boston. The research presented came from a retrospective cohort study that analyzed real-world data of users and nonusers […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Upcoming Release of Q1 2023 Financial Results, Schedules Earnings Call
May 4, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, plans to reports on its financial results for the first quarter ended March 31, 2023; the company will release the report on May 11, 2023, before market open. In addition, DarioHealth has scheduled an earnings conference call and webcast to discuss the report. The event […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Private Placement Pricing, Announces Credit Facility Refinance
May 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced the pricing of a $14.3 million private placement of convertible preferred stock. The announcement noted that the placement had been priced at the market under NASDAQ rules and included “significant participation by select members of leadership, the board and existing investors.” In addition, DarioHealth […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Appoints Digital Health Product Leader as Chief Product Officer
April 4, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that digital health veteran, Eitan Shay, is joining the company in the newly created position of chief product officer. Shay previously served in product leadership roles at digital health companies Livongo and Teladoc Health, as well as senior leadership roles at […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Digital Therapeutics Contract with Top-10 PBM
March 27, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has inked a new deal with a leading nationwide pharmacy benefits manager (“PBM”), the first contract that has resulted from the company’s strategic partnership with Sanofi U.S. The PBM operates in 50 states, and the agreement notes that the organization will begin the […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Amwell to Offer Valuable Access to Cardiometabolic Digital Therapeutic Solution
March 22, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has entered a new agreement with Amwell(R) (NYSE: AMWL), a leader in digital healthcare enablement. The agreement outlines the delivery of DRIO’s cardiometabolic solution to Amwell customers, with the potential to reach more than 90 million users; availability of the platform is anticipated to […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Study Results Published, Shows Potential for Digital Therapeutics in Pain Management
March 14, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting about new research related to machine learning and digital health solutions. The research, which was published in “Pain Reports,”evaluated the personalized efficacy of digital therapeutics for pain management, linking the reduction of back pain for users in a digital posture training. […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q4 and FY 2022 Results
March 9, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today reported financial results for the fourth quarter and full year 2022 and provided a corporate and commercial update. “During the fourth quarter, we continued to see substantial improvements in our financial results driven by our pivot to a business-to-business (‘B2B’) business model, […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Date for Execs to Host Q4 2022 Results Call
March 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has scheduled a date to release its fourth-quarter financial results for the period ended Dec. 31, 2022. DRIO CEO Erez Raphael, president Rick Anderson and CFO Zvi Ben-David will host the conference call and webcast on March 9, 2023; the event is slated […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Clinical Outcomes in Two New Studies at Diabetes Conference
February 27, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, reported on the results of two new clinical studies at the 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD); the event was held Feb. 22–25, 2023, in Berlin. Specifically, the company reported that one study demonstrated improved clinical outcomes in users […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) DarioHealth to Participate in Upcoming Cowen Health Care Conference
February 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that management will participate in the Cowen 43rd Annual Health Care Conference. The event is slated to take place March 6-8, 2023, at the Boston Marriott Copley Place in Boston, Massachusetts. The company’s CEO Erez Raphael and President Rick Anderson will […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Board Appointment of Health Care Industry Veteran
February 23, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced the appointment of Jon Kaplan to serve as a board member, effective immediately. As a managing director and senior partner at Boston Consulting Group (“BCG”), Kaplan serves as a core member of the strategy and health care practices and leading BCG’s […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expanding Platform to Integrate Market-Leading CGM Data
February 8, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced an agreement with DexCom (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (“CGM”) technology, to integrate its market-leading CGMs into Dario’s multi-chronic condition platform. “Nearly two million people use a continuous glucose monitor today, and the ability to capture […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Preliminary 2022 Operating Results, Eyes Continued Growth of B2B Revenue
February 6, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today released preliminary unaudited revenue results for the fourth quarter and full year 2022 of approximately $6.7 million and $27.5 million, respectively. According to the update, expected fourth quarter revenue shows a consecutive increase relative to the third quarter of 2022 ($6.6 million), […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Names New Senior VP
January 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that Matt Alberico has joined the company as a new senior vice president of growth. In his new role, Alberico will leverage his deep sales strategy experience in rapid-growth environments to help guide the company as it capitalizes on rapidly growing opportunities […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on New Research in Published Journal Article
January 9, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has published new research in the peer-reviewed journal, “Applied Sciences,” as part of a special issue featuring digital therapeutics applications for chronic disease management. The research shows improved outcomes for users living with diabetes across different racial and ethnic groups. According to the […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Validates Position as Leading Provider of Integrated Solutions in Employer and Payer Markets
January 3, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a large Northeast U.S. supermarket chain selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023. This marks 100 enterprise contracts signed for DarioHealth and validates its strategic position as a leading […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Delivering, Well-Positioned in ‘High-Demand’ Market
December 22, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced that it is “adding contracts with self-insured employers and national health plans as Amazon and CVS vie to lead value-based, patient-centric virtual healthcare.” According to the announcement, digital healthcare is delivering both better health outcome and also lower costs for the […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Move Device Reduces Back Pain, Study Shows
December 19, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting the publication of a new study in “Frontiers in Physiology,” a peer-reviewed journal; the study shows the effectiveness DRIO’s musculoskeletal solution, which uses real-time biofeedback and behavior training to reduce back pain. According to the announcement, the study evaluated retrospective data […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Accounts Utilizing Multi-Chronic Solution
December 1, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that two employers selected Dario as part of an offering from a leading benefits brokerage partner. According to the update, the employers will deploy Dario’s solutions to help improve the cardiometabolic and musculoskeletal health of employees beginning in the first quarter […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announce Participation in Upcoming Conferences
November 16, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, will be participating in two conferences scheduled for November: the Craig-Hallum Alpha Select Conference and the BTIG Digital Health Forum. Slated for Nov. 17, 2022, the 13th annual Craig-Hallum Alpha Select event will be held in New York City and features one-on-one meetings with […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q3 2022 Financial, Corporate Report
November 15, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has reported financial numbers and corporate updates for third quarter 2022. Highlights of the report include revenues of $6.6 million, an increase of 17.3% from the $5.6 million reported in Q3 2021, with B2B revenues growing to 63.5% of total revenue for the quarter, up from […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q3 2022 Results, Conference Call
November 9, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced it would release its financial results for the third quarter ended Sept. 30, 2022, after markets close on Monday, Nov. 14, 2022. The company will host a conference call and webcast at 8:30 am Eastern Time on Tuesday, Nov. 15, 2022, […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Employer Contracts to Provide Full Suite of Digital Health Solutions
October 20, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that it has inked two new contracts for the company’s full suite of chronic condition management solutions. DRIO solutions were chosen by the two employers to “help improve overall employee health.” Both contracts — one with a global Fortune 1000 company and one […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces 1st Contract with Government Benefits Entity
October 13, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a mid-sized Midwestern city selected Dario to provide its full suite of digital therapeutics solutions to several thousand city employees beginning in the first quarter of 2023. According to the update, the contract is Dario’s first with a government benefits […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes Promising Clinical Research for Its Biofeedback Posture Device
September 22, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced new research at the International Association of the Study of Pain (“IASP”) 2022 World Congress on Pain, being held in person in Toronto, Ontario, and virtually from September 19 – 23, 2022. The research examines the link between the use of […]